The FDA has announced plans to modernize and finalize its 510(k) clearance pathway as part of a continuing effort to advance the review of safety and effectiveness of medical devices, according to a recent statement from FDA Commissioner Scott Gottlieb, MD, and Jeff Shuren, MD, director of the FDA's Center for Devices and Radiological Health (CDRH).

CMS proposed several new policies for 2020 that aim to lower prescription drug prices by revising how Medicare plans can cover medicines and negotiate prices.

CVS Health received the final approval for its $69 billion merger with the nation’s third-largest health insurance provider, Aetna, on Nov. 26. CVS expects the deal to close Nov. 28, according to a new public filing.

After a federal judge blocked Kentucky’s Medicaid work requirements from going into effect earlier this year, CMS reapproved the program on Nov. 20.

Health insurers are using new methods to monitor consumers enrolled in their plans, as one person discovered when his sleep habits unknowingly played a role in the benefits he received from his provider, ProPublica reported.

State Reps. Angie Hatton and Robert Goforth have pre-filed legislation to roll back portions of Kentucky’s House Bill 2, which barred federally certified radiologists from reading x-rays in black lung compensation cases.

Senator Bernie Sanders (I-Vt.) and U.S. Representative Ro Khanna (D-Calif.) are planning to introduce a bill that aims to “drastically” lower prescription drug prices once Congress is back in session.

While the $69 billion merger between CVS Health and Aetna has moved through the regulatory review process, CVS executives now expect the deal to close after Thanksgiving, according to a new public filing. Executives previously anticipated the transaction would be completed before the holiday.